Pfizer – SF R&D Site Closure

Summary Pfizer announced the closure of its South San Francisco research site, citing underutilization and broader pressures in the biotech funding environment. The move reflects ongoing post-pandemic restructuring across large pharmaceutical companies and signals shifts in R&D footprint strategy. What Happened Pfizer is shutting down…